Main outcome measure: All- cause mortality at a mean follow-up of 37 months.

Primary end point was all- cause mortality within 90 days after index BSI.

The primary endpoint was all- cause mortality or major stroke at 1 year.

Results: Eight new metabolites were discovered to be associated with all- cause mortality.

The effect of on all- cause mortality was marginally significant for longer follow-up.

Log rank test showed no difference between treatment groups for all- cause mortality.

Patients with DKD have a higher risk of cardiovascular and all- cause mortality.

Clinical outcomes, including all- cause mortality, cardiovascular and renal end points, were examined.

The primary end point was all cause mortality in group III patients.

All- cause mortality and all-cause hospitalization increased with greater age in both sexes.

Conclusions: An SPPB score lower than 10 is predictive of all- cause mortality.

We describe a pooled analysis of all- cause mortality across 16 European countries.

Conclusions: Lower QOL is a powerful predictor of hospitalization and all- cause mortality.

Conclusions: RBC transfusion was not associated with AHF readmission or all- cause mortality.

Six-month cardiac and all- cause mortality were not significantly different between the groups.

The secondary endpoints were end-stage events comprising all- cause mortality and heart transplantation.